(Q58215181)

English

Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil

article

In more languages
default values for all languages
No label defined

No description defined

Statements

Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil (English)
0 references
0 references
0 references
0 references
0 references
Tiffany Ting-Fang Shih
0 references
0 references
0 references
Ying-Chun Shen
0 references
Chiun Hsu
0 references
Fu-Chang Hu
0 references
October 2011
0 references
55
0 references
4
0 references
858-865
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit